james shehan

LS Lowenstein Sandler More Lowenstein Sandler is a national law firm with over 350 lawyers working from five offices in New York, Palo Alto, New Jersey, Utah, and Washington, D.C. We represent clients in virtually every sector of the global economy, with particular strength in the areas of technology, life sciences, and investment funds.

The U.S. Drug Enforcement Administration (DEA) is on the brink of reclassifying marijuana, marking a watershed moment in American drug policy. For decades, marijuana has been classified as a Schedule I drug, alongside substances like heroin, ecstasy, and LSD, under the Controlled Substances Act. The proposed reclassification of marijuana from Schedule I to Schedule III represents a shift in federal drug policy.